FDA Approved: LEVETIRACETAM — Original Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved the original application for levetiracetam as a generic product from BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures
• Juvenile Myoclonic Epilepsy
• Myoclonic Seizures
• Partial-onset Seizures

Drugs mentioned

• Levetiracetam (generic) (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)